Connective Issue #15

MIB News
Connective Issue #15

Volume 15 | November 1, 2023

Be the "I" in MIB

With the collective contributions in science, patient support, donations, and time, we know our osteosarcoma community understands that you have to be the change you wish to see in the world. We encourage you to Be the "I" in MIB this month to Make It Better for osteosarcoma patients and families.

- Submit an abstract to present at FACTOR 2024 - due January 12th, 2024

- Apply for an OutSmarting Osteosarcoma research grant - due January 26, 2024

- Donate to MIB on Giving Tuesday - November 28th

- Become a Writer Agent and spread love, hope, and cheer to OsteoWarriors

November is Pet Cancer Awareness month and since nearly 10,000 dogs in are diagnosed with osteosarcoma each year in the US, we know we need to Make It Better for our dog companions too. Research in dogs will also help lead to better treatment for kids. We have just published a Canine Osteosarcoma Clinical Trials resource on our site to help direct canine patients and their families to cutting-edge treatments that will advance our understanding of osteosarcoma.  

Wishing you and your families a restful Thanksgiving. We are grateful always for all this community gives to Make It Better with us.

With hope,


Save The Date

Our Community

Make It Better with a Community Fundraiser

Thank you for all the ways you show up for our community! As the season of giving approaches, we invite you to contribute an item to our OutBidding Osteosarcoma online auction next spring. Interested in hosting a community fundraiser for MIB Agents? We'd love to hear from you!

Donate Auction Item

Host a Fundraiser

Order a Golden Petals of Hope 2024 Calendar

Pre-order our limited edition Golden Petals of Hope 2024 Calendar featuring photography by Osteomom & MIB Volunteer, Lisa Skrubis, in honor of her daughter and OsteoWarrior, Kara.

Each month showcases stunning and vibrant sunflowers which symbolize hope in the osteosarcoma community. Let the radiant beauty of sunflowers uplift your spirit and brighten your days in 2024!

Pre-Order a Calendar

Welcome Nicolas Garnier to our SAB

Please join us in welcoming Nicolas Garnier, PhD to the MIB Agents Scientific Advisory Board.  Nicolas is an osteosarcoma survivor, with a MS in Cancer Genetics from Denis Diderot University (Paris, FR) and a PhD in Experimental Medicine from McGill University. He is currently Head of Patient Advocacy, at Pfizer Research & Development. With his personal osteosarcoma experience, industry role, and scientific academic background, he shares our passion to Make It Better and will bring valuable perspective to our SAB.

Read More About Nicolas Garnier

Career Connection

  1. D4CG Project Manager
  2. Senior Research Technician - Majzner Pediatrics Lab
  3. Sarcoma Faculty Clinician/Translational Researcher/Physician Scientist at OHSU
  4. Postdoctoral and staff scientists in the Curtis Lab at Stanford Medicine
  5. Behavioral Health Staff Scientist in the Psychosocial Support and Research Program, Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health (NIH)

If you have a job posting and you would like it included here, please email


OsteoBites Q&A in Spanish

Know Spanish speaking osteosarcoma patients and families? Please share our OsteoBites Q&A in Spanish featuring Dr. Nino Rainusso from Texas Children's Hospital, OsteoWarrior Eva, and Noriela Elia from the Count Me In Osteosarcoma Project.

OsteoBites Webinar Series

Nov 2 | OutSmarting Osteosarcoma
On demand overview of the 2023-2024 OutSmarting Osteosarcoma Research Grant Program Applications due 1/26/24
Nov 16 | osTEAo AYA podcast
Long Term Osteosarcoma Survivors: Where They Were and Where They Are Now
Nov 30 | Ming Li, PhD
Immunological Mechanisms of Cancer Defense
Dec 7 | Joshua Nash
Developing a Multiscale Transcriptional Atlas of Sarcoma

Watch Past Episodes and See the Upcoming Schedule

Tumor Review Board for Osteosarcoma

A virtual tumor review board for osteosarcoma, TURBO is open to global clinicians or researchers with an interest in osteosarcoma.  Patients and families are welcome to ask their oncologists to present a case on their behalf.  Join TURBO to request an invite or submit a case.

Next meeting: November 8th at 5pm ET


Osteosarcoma in the News


Join Our Team of Superhero Writer Agents!

From Jaden's mom: “Jaden continues to enjoy his Warrior Mail. We look at it together sometimes, and it’s truly amazing what others will do to bring a smile to my son’s face. The small details make the mail so special! Please send our thanks and appreciation to all our warrior mail friends!”

Each month our Superhero Writer Agents send cards and letters to our brave Osteo Warriors. We email a list of Warrior Intel on each of our young warriors to our Writer Agents. A couple of weeks later, we receive their messages of love and support to Warrior Mail HQ. We then sort and ship packages to each Warrior who look forward to receiving the monthly package topped off with small gifts and treats from MIB! Once you sign up to be a Writer Agent, you will receive a link to the Warrior Mail Handbook and our invitation to join the MIB Agent Writer FaceBook page.

The Holiday 2023 Warrior Mail schedule is as follows:

Intel emailed to Writer Agents:  November 19th

Deadline for delivery to your local P.O. for mailing to Warrior Mail HQ:  December 4th!
Departure of Priority Mail Packages from MIB HQ to Warriors: December 11th

Thank you and all of the volunteers for making the Warrior Mail so special!

To learn more,  please contact

Become a Writer Agent

Receive Warrior Mail


Apply Now for OutSmarting Osteosarcoma

The OutSmarting Osteosarcoma 2024 research grant application is now open on Proposal Central! Applications are due January 26, 2024, with notification in May 2024. Awards include a $100,000 one year and a $50,000 Young Investigator one year grant.

Apply for a Research Grant

Submit an Abstract for FACTOR 2024!

Have a compelling topic to share with the osteosarcoma community?

We want to hear about it! MIB Agents is now accepting abstract submissions for oral presentations at FACTOR 2024. Abstracts can be created, modified, and submitted online at Proposal Central until January 12, 2024.

Submit an Abstract

Learn More

Canine Osteosarcoma Clinical Trials

Osteosarcoma is the most common primary bone tumor of dogs. The incidence of osteosarcoma in dogs is anywhere from 10-50x higher than in humans.  Research in dogs will one day mean better treatment for kids. Check out the MIB Canine Clinical Trials resource which provides an overview of canine trials, a list of veterinary oncology institutions, and a list of canine osteosarcoma trials.

Learn about Canine Osteosarcoma Trials

If you have a trial that is currently enrolling osteosarcoma patients, please email

All MIB Agents programs are free of charge, thanks to our generous donors like you who Make it Better.
Please consider a donation to support osteosarcoma patient programs, education, and research.


Other blog posts